source
- Qiagen appoints new chief executive after 9-month searchMolecular diagnostics specialist Qiagen has a new CEO as Jonathan M. Pratt takes the reins.Fierce Biotech · 9h ago↗ source
- TME holds onto $1B dream for brain cancer drug as search for partners nears conclusionTME Pharma’s hunt for a partner for its brain cancer drug is closer to bearing fruit as the German biotech clings to its hope of generating $1 billion in peak sales from the asset.Fierce Biotech · 9h ago↗ source
- Merck and Moderna’s personalized mRNA vaccine shows longer recurrence-free survival in phase 3 melanoma trialMerck and Moderna reported that their individualized mRNA cancer vaccine, given together with Keytruda, extended the time patients remained free of melanoma recurrence in a late-stage study. The p…